Lauren Silvernail has served as our Chief Financial Officer and Executive Vice President, Corporate Development since May 2018. From 2013 to 2018, Lauren served as the CFO and Executive VP, Corporate Development of Revance Therapeutics, Inc. and from 2015 to 2018 was also Chief Business Officer. From 2003 to 2012, Lauren was CFO and VP of Corporate Development at ISTA Pharmaceuticals, Inc. From 1995 to 2003, she served in various operating and corporate development positions with Allergan, Inc., including VP, Business Development. Prior to joining Allergan, Inc., Lauren worked at Glenwood Ventures, an investment firm, as a General Partner. She currently serves on the board of directors and the audit committee of Nicox S.A. Lauren holds a B.A. in Biophysics from the University of California, Berkeley and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.
